AirDuo ® Digihaler™ (fluticasone propionate/salmeterol) – New formulation approval
July 15, 2019 - Teva announced the FDA approval of AirDuo (fluticasone propionate/salmeterol) inhalation powder, for the treatment of asthma in patients aged 12 years and older.
Download PDF
